Flagship Harbor Advisors LLC boosted its position in shares of CVS Health Co. (NYSE:CVS – Get Rating) by 7.2% in the first quarter, Holdings Channel.com reports. The firm owned 31,801 shares of the pharmacy operator’s stock after acquiring an additional 2,135 shares during the period. Flagship Harbor Advisors LLC’s holdings in CVS Health were worth $3,219,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Acropolis Investment Management LLC grew its holdings in CVS Health by 77.1% during the 1st quarter. Acropolis Investment Management LLC now owns 3,018 shares of the pharmacy operator’s stock valued at $305,000 after purchasing an additional 1,314 shares in the last quarter. Glassy Mountain Advisors Inc. grew its holdings in CVS Health by 1.1% during the 1st quarter. Glassy Mountain Advisors Inc. now owns 72,680 shares of the pharmacy operator’s stock worth $7,356,000 after acquiring an additional 825 shares in the last quarter. Zeke Capital Advisors LLC grew its holdings in CVS Health by 31.7% during the 3rd quarter. Zeke Capital Advisors LLC now owns 12,182 shares of the pharmacy operator’s stock worth $1,034,000 after acquiring an additional 2,933 shares in the last quarter. Auxier Asset Management grew its holdings in CVS Health by 1.0% during the 3rd quarter. Auxier Asset Management now owns 108,859 shares of the pharmacy operator’s stock worth $9,238,000 after acquiring an additional 1,093 shares in the last quarter. Finally, Farmers & Merchants Investments Inc. grew its holdings in CVS Health by 1.5% during the 4th quarter. Farmers & Merchants Investments Inc. now owns 263,517 shares of the pharmacy operator’s stock worth $27,184,000 after acquiring an additional 3,894 shares in the last quarter. 78.00% of the stock is owned by institutional investors and hedge funds.
Several research analysts have weighed in on CVS shares. StockNews.com started coverage on shares of CVS Health in a report on Thursday, March 31st. They set a “strong-buy” rating for the company. Deutsche Bank Aktiengesellschaft raised their price objective on shares of CVS Health from $110.00 to $113.00 in a report on Thursday, May 5th. Loop Capital initiated coverage on shares of CVS Health in a research report on Thursday, June 16th. They issued a “buy” rating and a $120.00 price target on the stock. Tigress Financial raised their price target on shares of CVS Health from $122.00 to $125.00 in a research report on Thursday, April 7th. Finally, Sanford C. Bernstein downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $122.00 to $112.00 in a research report on Thursday, May 26th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $116.05.
CVS Health (NYSE:CVS – Get Rating) last released its quarterly earnings results on Wednesday, May 4th. The pharmacy operator reported $2.22 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.08. The company had revenue of $76.83 billion for the quarter, compared to the consensus estimate of $75.30 billion. CVS Health had a net margin of 2.67% and a return on equity of 15.33%. CVS Health’s revenue was up 11.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.04 EPS. On average, equities research analysts predict that CVS Health Co. will post 8.34 earnings per share for the current year.
In other news, EVP Prem S. Shah sold 16,954 shares of CVS Health stock in a transaction that occurred on Friday, April 8th. The shares were sold at an average price of $105.00, for a total value of $1,780,170.00. Following the transaction, the executive vice president now owns 43,453 shares of the company’s stock, valued at approximately $4,562,565. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Daniel P. Finke sold 55,359 shares of CVS Health stock in a transaction that occurred on Monday, April 4th. The stock was sold at an average price of $100.13, for a total transaction of $5,543,096.67. Following the completion of the transaction, the executive vice president now directly owns 3,098 shares in the company, valued at $310,202.74. The disclosure for this sale can be found here. Insiders sold a total of 77,659 shares of company stock worth $7,882,993 in the last ninety days. Corporate insiders own 0.69% of the company’s stock.
CVS Health Company Profile (Get Rating)
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
- Get a free copy of the StockNews.com research report on CVS Health (CVS)
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.